AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2018
May 25, 2018
30237_dirs_2018-05-25_55ff2270-b090-45ac-879d-e5420fdfc260.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2018-05-23
Reporting Person: KING DAVID P (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-23 | Common Stock | M | 49966 | $84.86 | Acquired | 271635.3298 | Direct |
| 2018-05-23 | Common Stock | S | 44566 | $175.2738 | Disposed | 227069.3298 | Direct |
| 2018-05-23 | Common Stock | S | 5400 | $176.1281 | Disposed | 221669.3298 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-23 | Non-qualified Stock Options | $84.86 | M | 49966 | Disposed | 2022-05-23 | Common Stock (49966) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 27811 | Indirect |
| Common Stock | 47357 | Indirect |
Footnotes
F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: The price of $175.2738 per share represents a weighted average of sales prices ranging from $175.00 to $175.998 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F3: The price of $176.1281 per share represents a weighted average of sales prices ranging from $176.01 to $176.54 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F4: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F5: The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable.